Syntactx, Now Part of NAMSA | 4,694 followers on LinkedIn. Syntactx is a leading, full-service CRO with deep expertise in complex, interventional medical device and drug trials. Led by key thought leaders who understand first-hand what's at stake, clients count on us to synthesize the clinical evidence behind their innovative products for market approvals and broad market adoption. We provide solutions for: • Market Leaders • Emerging Companies • Early-Stage Startups • Physicians and Institutions Having long careers in clinical practice and academia, our world-renowned physicians were national principal investigators on multiple, landmark clinical trials for medicine’s most advanced technologies.